pHBSP Modified Single-Letter Sequence: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser IUPAC Condensed Amino Acid Sequence: Pyroglutamic-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser Molecular Weight: 1257.3 g/mol CAS Number: 1208243-50-8 PubChem CID : 91810664 Further Reference: PubChem Link Stability : Stable for up to 36 months when stored at 20 C or colder, protected from light and moisture
However, the insurer states that overall GLP-1 therapy plan spend is unlikely to decline in future years due to growing use and continued expansion of GLP-1 therapies
Weight loss procedures such as calorie restriction and metabolic/bariatric surgery are known to affect bone health because they elevate bone turnover markers (BTMs) and reduce bone mineral density (BMD) [7,8,9]
Both share similar research applications
The most symptoms reported represent those already known from clinical trials, gastrointestinal issues, as reported by 43.5% of users
Several biomarkers are being investigated as possible and better indicators of disease progression with the aim of replacing the standard of diagnosis, which remains an invasive procedure (biopsy) [4, 18]